A lightspot for CUPIDO at the European Society of Cardiology Congress 2019

Home / eventi / A lightspot for CUPIDO at the European Society of Cardiology Congress 2019

This year CUPIDO arouse interest during the European Society of Cardiology Congress, one of the world’s largest and most influential cardiovascular event contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2019 took place 31 August to 4 September at the Paris Expo Porte de Versailles, Paris – France.

Our project coordinator Daniele Catalucci and a representative of our pharma partner SANOFI, were there to present the innovative delivery system to the heart that CUPIDO is developing.  Dr. Catalucci presented the latest results showing that a novel inhaled miR-133-loaded nanoparticle delivery approach can prevent cardiac dysfunction in an experimental model (Abstract 3072). The presentation of Daniele was first highlighted in the Daily Science News distributed to all the participants (available online too), and it was also selected as one of the Congress Condensed Basic Science Highlights presented during the last day. 

The interest is well deserved as this proof of concept has never been shown before for miRNAs and inhalation.  This important work is at the core of the CUPIDO project which is now in the process of scaling up the production for the evaluation in large-animal models, thus paving the way for future health applications of the CUPIDO inhalable nanoparticles. The efforts of the whole Consortium are well paid back by this recognition at such important scientific event.